Conference Presentation slide image

Conference Presentation

na Our Tobacco Franchise We are setting the stage for a successful launch of VLNⓇ, our proprietary reduced nicotine cigarettes containing 95% less nicotine than conventional counterparts X The FDA has authorized 22nd Century to sell its reduced nicotine content tobacco cigarettes in the U.S. 22nd Century Group, Inc. Develop and commercialize GMO and non-GMO varieties of 95% reduced nicotine tobacco Premarket Tobacco Product Application (PMTA) Modified Risk Tobacco Product Application (MRTPA) An MRTP authorization would allow 22nd Century to make powerful marketing and advertising claims, in the U.S. under the brand name VLNⓇ, distinguishing the product from conventional cigarettes CONTINUE TO SUPPORT THE FDA'S PROPOSED PLAN FOR THE ADOPTION OF A REDUCED NICOTINE PRODUCT STANDARD FOR ALL COMBUSTIBLE CIGARETTES
View entire presentation